Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Fri, 14 August 2026
What it is about
Mazen NoureddinJack CallicuttJoel LewisKevin GardnerNaim AlkhouriCompany Annual Report On FormGalectin Therapeutics IncTerms Of ServiceSummit Clinical ResearchNasdaqBelapectin ProgramSteatotic Liver Program At North Shore GastroenterologyDrug AdministrationExchange CommissionCompany Quarterly Report On FormCompany ContactHouston, Texas, United StatesManila, Manila, Philippines
Who published it, and when
How it spread - 1 original report
Fri, 14 August 2026
1 report- manilatimes.net12:17first to report
NORCROSS, Ga., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ended June 30, 2026.